Neste Jacobs and National Bioproducts Institute

sign a biopharma agreement

  • January 11, 2013
  • Neste Jacobs and National Bioproducts Institute
    Neste Jacobs and National Bioproducts Institute

Technology, engineering and project management company Neste Jacobs Oy and the South African plasma fractionation company National Bioproducts Institute have signed a service agreement covering production consulting, engineering and executing of services related to plasma fractionation processes.

Under the agreement Neste Jacobs will carry out engineering, procurement, construction/installation, qualification, and validation services for National Bioproducts Institute in South Africa. Neste Jacobs' expertise in plasma fractionation unit operations, operational aspects and knowledge of particular features of plasma fractionation processes has made the company a leading partner in the field. The agreement between the two companies aligns with Neste Jacobs' strategy to assist governments and other health care providers worldwide to become self-sufficient in the manufacture of blood plasma products.

"We are very happy to co-operate with National Bioproducts Institute. Blood plasma fractionation is a substantial and growing part of our business and, together with our other core competences, ensures our growth globally," says Neste Jacobs' Managing Director Jarmo Suominen.

"We have been very satisfied with Neste Jacobs' delivery and performance and based on this experience they were a natural choice for us," says David Stubbings, the CEO of National Bioproducts Institute. "We wanted a strong partner with solid experience in the plasma products industry and in this respect Neste Jacobs was our first choice.